Cancer Drug Research and Development, San Diego, CA, USA
Event Nov 20
Organized into six sessions: Therapeutic Angiogenesis and Anti-angiogenesis, Metabolic Syndrome and Cardiovascular Disease, Hybrid Technologies: Biologics, Devices and Molecular Strategies, New Platform Technologies for Cardiovascular Drug Development, Therapeutic Strategies in Arrhythmogenesis, and Cardiovascular Gene and Cell Based Therapies. This event will also feature keynote speeches by Drs. Gianni Gromo (Sr. VP, Roche) and Andrew Marshall (Editor, Nature Biotechnology).